The benzodiazepine antagonist Ro 15-1788 does not antagonize the ethanol withdrawal syndrome
- 1 June 1986
- journal article
- research article
- Published by Elsevier in Biological Psychiatry
- Vol. 21 (7), 643-649
- https://doi.org/10.1016/0006-3223(86)90125-3
Abstract
No abstract availableThis publication has 26 references indexed in Scilit:
- Cerebrospinal Fluid 3-Methoxy-4-hydroxyphenylglycol and Norepinephrine Levels in Alcohol WithdrawalArchives of General Psychiatry, 1985
- Noradrenergic Function and the Mechanism of Action of Antianxiety TreatmentArchives of General Psychiatry, 1985
- New endogenous benzodiazepine receptor ligand in human urine: Identity with endogenous monoamine oxidase inhibitor?Life Sciences, 1983
- Yohimbine induced anxiety and increased noradrenergic function in humans: Effects of diazepam and clonidineLife Sciences, 1983
- Central toxic effects of chronic ethanol treatment: Actions on GABA and benzodiazepine recognition sitesToxicology Letters, 1982
- The benzodiazepine/GABA receptor complex during severe ethanol intoxication and withdrawal in the ratActa Psychiatrica Scandinavica, 1982
- Benzodiazepine antagonist Ro 15-1788: Neurological and behavioral effectsPsychopharmacology, 1982
- Benzodiazepines attenuate single unit activity in the locus coeruleusLife Sciences, 1980
- Physiologic and Pathologic TremorsAnnals of Internal Medicine, 1980
- Minor tranquillizers, stress and central catecholamine neuronsBrain Research, 1971